Impact of Sophrology on cardiopulmonary fitness in teenagers and young adults with a congenital heart disease: The SOPHROCARE study rationale, design and methods.
Congenital heart defect
Exercise capacity
Health-related quality of life
Relaxation
Sophrology
VO2max
Journal
International journal of cardiology. Heart & vasculature
ISSN: 2352-9067
Titre abrégé: Int J Cardiol Heart Vasc
Pays: Ireland
ID NLM: 101649525
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
30
10
2019
revised:
17
02
2020
accepted:
20
02
2020
entrez:
11
3
2020
pubmed:
11
3
2020
medline:
11
3
2020
Statut:
epublish
Résumé
Recent advances in the field of congenital heart disease (CHD) have significantly improved the overall prognosis. Now more attention is being given to health-related quality of life (HRQoL) and promotion of physical activity. Non-invasive relaxation therapy may be effective in cardiac patients concerned with exercise-induced dyspnoea. The SOPHROCARE randomised trial aims to assess the impact of Caycedian Sophrology on cardiopulmonary fitness in adolescents and young adults with CHD. The SOPHROCARE trial is a nationwide, multicentre, randomised, controlled study in CHD patients aged from 13 to 25 years old. Patients will be randomised into 2 groups (8 Sophrology group sessions vs. no intervention). The primary outcome is the change in percent predicted maximum oxygen uptake (VO2 After focusing on the survival in CHD, current research is opening on secondary prevention and patient-related outcomes. We sought to assess in the SOPHROCARE trial, if a Sophrology program, could improve exercise capacity and quality of life in youth with CHD. Clinicaltrials.gov (NCT03999320).
Sections du résumé
BACKGROUND
BACKGROUND
Recent advances in the field of congenital heart disease (CHD) have significantly improved the overall prognosis. Now more attention is being given to health-related quality of life (HRQoL) and promotion of physical activity. Non-invasive relaxation therapy may be effective in cardiac patients concerned with exercise-induced dyspnoea. The SOPHROCARE randomised trial aims to assess the impact of Caycedian Sophrology on cardiopulmonary fitness in adolescents and young adults with CHD.
METHODS
METHODS
The SOPHROCARE trial is a nationwide, multicentre, randomised, controlled study in CHD patients aged from 13 to 25 years old. Patients will be randomised into 2 groups (8 Sophrology group sessions vs. no intervention). The primary outcome is the change in percent predicted maximum oxygen uptake (VO2
CONCLUSION
CONCLUSIONS
After focusing on the survival in CHD, current research is opening on secondary prevention and patient-related outcomes. We sought to assess in the SOPHROCARE trial, if a Sophrology program, could improve exercise capacity and quality of life in youth with CHD.
TRIAL REGISTRATION
BACKGROUND
Clinicaltrials.gov (NCT03999320).
Identifiants
pubmed: 32154361
doi: 10.1016/j.ijcha.2020.100489
pii: S2352-9067(19)30284-2
pii: 100489
pmc: PMC7057190
doi:
Banques de données
ClinicalTrials.gov
['NCT03999320']
Types de publication
Journal Article
Langues
eng
Pagination
100489Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
None.
Références
Paediatr Anaesth. 2018 Jun;28(6):528-536
pubmed: 29701278
Med Care. 2001 Aug;39(8):800-12
pubmed: 11468499
Congenit Heart Dis. 2019 Sep;14(5):778-784
pubmed: 31066183
Circulation. 2013 May 28;127(21):2147-59
pubmed: 23630128
J Appl Physiol Respir Environ Exerc Physiol. 1984 Mar;56(3):628-34
pubmed: 6706770
Ethn Dis. 2007 Winter;17(1):72-7
pubmed: 17274213
Evid Based Complement Alternat Med. 2007 Dec;4(4):409-17
pubmed: 18227907
Soins. 2012 Mar;(763):16-20
pubmed: 22533280
Eur J Cardiovasc Nurs. 2019 Feb;18(2):163-170
pubmed: 30230358
Eur J Prev Cardiol. 2012 Oct;19(5):1034-65
pubmed: 23126001
J Consult Clin Psychol. 1976 Jun;44(3):406-12
pubmed: 932270
J Am Coll Cardiol. 2018 May 29;71(21):2434-2446
pubmed: 29793633
Int J Cardiol. 2019 Jun 15;285:86-92
pubmed: 30857849
Int J Cardiol. 2016 Jan 15;203:1052-60
pubmed: 26638054
Pediatr Cardiol. 2016 Feb;37(2):217-24
pubmed: 26396114
Orphanet J Rare Dis. 2011 Oct 03;6:64
pubmed: 21968022
Qual Health Res. 2011 Feb;21(2):278-91
pubmed: 20935236
Pediatr Cardiol. 2015 Dec;36(8):1588-601
pubmed: 26024647
Pediatrics. 2016 Sep;138(3):
pubmed: 27550982
Chest. 1992 Feb;101(2):485-9
pubmed: 1735277
Health Policy. 2016 Jul;120(7):818-32
pubmed: 27114104
J Appl Physiol (1985). 1993 Apr;74(4):1475-83
pubmed: 8514660
Paediatr Child Health. 2009 Mar;14(3):167-70
pubmed: 20190897
Circulation. 2013 Feb 26;127(8):882-90
pubmed: 23382015
J Obstet Gynaecol Can. 2018 Feb;40(2):227-245
pubmed: 29447711
Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):51-58
pubmed: 28950356
Pediatr Pulmonol. 2018 May;53(5):559-566
pubmed: 29493875
Circulation. 2016 May 17;133(20):1951-62
pubmed: 27185022
Int J Cardiol. 2019 Oct 1;292:230-235
pubmed: 31256996
Compr Physiol. 2012 Apr;2(2):1143-211
pubmed: 23798298
Rev Epidemiol Sante Publique. 1998 Feb;46(1):49-55
pubmed: 9533234
Eur Heart J. 2010 Dec;31(23):2915-57
pubmed: 20801927
Rev Infirm. 2017 Dec;66(236):37-39
pubmed: 29179847
J Health Psychol. 2018 Feb 1;:1359105318755263
pubmed: 29402140
Patient Educ Couns. 2019 Dec;102(12):2223-2230
pubmed: 31262673
J Psychosom Res. 2012 Sep;73(3):157-62
pubmed: 22850253
G Anest Stomatol. 1986 Oct-Dec;15(4):25-8
pubmed: 3552902
Eur Heart J. 2009 Dec;30(23):2915-20
pubmed: 19692392
Br J Sports Med. 2011 May;45(6):498-503
pubmed: 19679577
Heart. 2018 Jun;104(12):1026-1036
pubmed: 29170358
Pediatr Cardiol. 2018 Jan;39(1):79-88
pubmed: 28980091
Soins. 2015 Nov;(800):17-20
pubmed: 26567064
Int J Cardiol. 2019 May 15;283:112-118
pubmed: 30616811